{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:05:40Z","timestamp":1777633540289,"version":"3.51.4"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Enteral nutrition (EN) is essential for Inflammatory Bowel Disease treatment. This applies mainly to Crohn\u2019s disease (CD) and ulcerative colitis (UC) patients. The study evaluated the impact of EN treatment on clinical, nutritional, inflammatory, and quality of life outcomes in IBD patients. This study aimed to examine the association between EN therapy\u2019s clinical, nutritional, inflammatory, and Quality of Life (QoL) effects on Inflammatory Bowel Disease patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective study investigated 750 Chinese IBD patients. These patients had 400 CD and 350 UC diagnoses. Medical records provided data. EN formula, administration, calorie density, and duration were studied along with disease activity, nutritional markers including hemoglobin, albumin, and body mass index, and inflammatory indices like erythrocyte sedimentation rate. Validated IBDQ measures quality of life. Clinical remission was defined as a Crohn\u2019s Disease Activity Index (CDAI) score &amp;lt; 150 for CD patients and a Mayo score \u2264 2 (with no individual subscore &amp;gt; 1) for UC patients, assessed after completion of EN therapy. Chi-square and\n                      <jats:italic>t<\/jats:italic>\n                      -tests were used for statistical analysis, with a significance level of\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.05.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Baseline characteristics of 750 patients are comparable between groups. Elemental and semi-elemental formulas were more frequently prescribed in CD patients and were associated with higher caloric and protein intake (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.05). Approximately 60% of patients achieved clinical remission after 6 \u00b1 2 weeks of EN therapy (62.5% CD vs. 57.1% UC). Improvements in BMI, albumin, hemoglobin, and CRP were observed in patients receiving EN, along with increased IBDQ scores. Adverse effects were minor (8%). Full adherence (OR = 2.15,\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001) and longer EN duration (&amp;gt;6 weeks) were independently associated with higher odds of remission and QoL improvement.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>EN therapy corresponded with clinical remission, improved nutritional markers, and reduced inflammation in IBD patients, particularly those with CD. These findings support the potential role of EN as a complementary strategy in IBD management; however, prospective randomized trials are further confirming these associations and standardize therapeutic protocols.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1759869","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:41:11Z","timestamp":1777437671000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of enteral nutrition in the clinical care, management, and quality of life of patients with inflammatory bowel disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Qian","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, The Second Affiliated Hospital of Soochow University","place":["Suzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianlan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Second Affiliated Hospital of Soochow University","place":["Suzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruidong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Second Affiliated Hospital of Soochow University","place":["Suzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Second Affiliated Hospital of Soochow University","place":["Suzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Second Affiliated Hospital of Soochow University","place":["Suzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.3390\/diagnostics14141530","article-title":"comprehensive multidisciplinary approach to diagnosing chronic inflammatory bowel diseases: integration of clinical, endoscopic, and imaging modalities.","volume":"14","author":"Cicerone","year":"2024","journal-title":"Diagnostics."},{"key":"B2","doi-asserted-by":"publisher","first-page":"17562848241290685","DOI":"10.1177\/17562848241290685","article-title":"Exploring the management and treatment of IBD from the perspective of psychological comorbidities.","volume":"17","author":"Feng","year":"2024","journal-title":"Therapeutic Adv Gastroenterol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ajg.2018.27","article-title":"ACG clinical guideline: management of Crohn\u2019s disease in adults.","volume":"113","author":"Lichtenstein","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"765474","DOI":"10.3389\/fmed.2021.765474","article-title":"Treatment of inflammatory bowel disease: a comprehensive review.","volume":"8","author":"Cai","year":"2021","journal-title":"Front Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5142","DOI":"10.3390\/jcm12155142","article-title":"Global epidemiology and burden of elderly-onset inflammatory bowel disease: a decade in review.","volume":"12","author":"Danpanichkul","year":"2023","journal-title":"J Clin Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s44197-023-00145-w","article-title":"Evolving trends and burden of inflammatory bowel disease in Asia, 1990\u20132019: a comprehensive analysis based on the global burden of disease study.","volume":"13","author":"Chen","year":"2023","journal-title":"J Epidemiol Glob Health."},{"key":"B7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/antiox10010064","article-title":"Oxidative stress in the pathogenesis of Crohn\u2019s disease and the interconnection with immunological response, microbiota, external environmental factors, and epigenetics.","volume":"10","author":"Alemany-Cosme","year":"2021","journal-title":"Antioxidants."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1080\/1744666X.2022.2108407","article-title":"Genes vs environment in inflammatory bowel disease: an update.","volume":"18","author":"Dipasquale","year":"2022","journal-title":"Expert Rev Clin Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1080\/17474124.2025.2508970","article-title":"Management of inflammatory bowel disease: a holistic approach beyond pharmacotherapy.","volume":"19","author":"Mourad","year":"2025","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3390\/nu17091481","article-title":"Enteral nutrition in Crohn\u2019s disease: a comprehensive review of its role in induction and maintenance of remission and perioperative management in adult patients.","volume":"17","author":"Bargas","year":"2025","journal-title":"Nutrients."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.3390\/nu16213581","article-title":"Mechanisms of action of exclusive enteral nutrition and other nutritional therapies in Crohn\u2019s disease.","volume":"16","author":"Geesala","year":"2024","journal-title":"Nutrients."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3390\/medicina60071068","article-title":"comprehensive review of dietary approaches in maintaining remission of inflammatory bowel diseases in adults.","volume":"60","author":"Istratescu","year":"2024","journal-title":"Medicina."},{"key":"B13","doi-asserted-by":"publisher","first-page":"718356","DOI":"10.3389\/fnut.2021.718356","article-title":"Inflammatory and microbiota-related regulation of the intestinal epithelial barrier.","volume":"8","author":"Barbara","year":"2021","journal-title":"Front Nutr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.3390\/nu16203523","article-title":"Personalized nutrition in the pediatric ICU: steering the shift from acute stress to metabolic recovery and rehabilitation.","volume":"16","author":"Briassoulis","year":"2024","journal-title":"Nutrients."},{"key":"B15","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/0016-5085(89)90905-0","article-title":"A new measure of health status for clinical trials in inflammatory bowel disease.","volume":"96","author":"Guyatt","year":"1989","journal-title":"Gastroenterology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/ecco-jcc\/jjac138","article-title":"The incidence and prevalence of paediatric- and adult-onset inflammatory bowel disease in denmark during a 37-year period: a nationwide cohort study (1980-2017).","volume":"17","author":"Dorn-Rasmussen","year":"2023","journal-title":"J Crohns Colitis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1136\/gutjnl-2022-327845","article-title":"Antibiotic use as a risk factor for inflammatory bowel disease across the ages: a population-based cohort study.","volume":"72","author":"Faye","year":"2023","journal-title":"Gut."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S2468-1253(24)00159-6","article-title":"Sex and gender in inflammatory bowel disease outcomes and research.","volume":"9","author":"Andersen","year":"2024","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3390\/gidisord6020038","article-title":"Rising incidence of inflammatory bowel disease in the Asian subcontinent\u2014an exploration of causative factors.","volume":"6","author":"Bhayani","year":"2024","journal-title":"Gastrointestinal Disord."},{"key":"B20","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1093\/ibd\/izab345","article-title":"Prevalence of malnutrition, its risk factors, and the use of nutrition support in patients with inflammatory bowel disease.","volume":"28","author":"Liu","year":"2022","journal-title":"Inflammatory Bowel Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S2468-1253(23)00011-0","article-title":"Inflammation and malnutrition in inflammatory bowel disease.","volume":"8","author":"Massironi","year":"2023","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.3390\/nu15173824","article-title":"Nutrition, nutritional status, micronutrients deficiency, and disease course of inflammatory bowel disease.","volume":"15","author":"Valvano","year":"2023","journal-title":"Nutrients."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.3390\/jcm14072296","article-title":"Modifiable factors influencing disease flares in inflammatory bowel disease: a literature overview of lifestyle, psychological, and environmental risk factors.","volume":"14","author":"Koppelman","year":"2025","journal-title":"J Clin Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.gastrohep.2021.05.004","article-title":"Alcohol use in patients with inflammatory bowel disease.","volume":"17","author":"Ramos","year":"2021","journal-title":"Gastroenterol Hepatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1093\/ibd\/izae020.082","article-title":"Shifts in IBD incidence, mortality, and burden: a comprehensive analysis of us and global trends (1990-2019).","volume":"30","author":"Maddineni","year":"2024","journal-title":"Inflammatory Bowel Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/ibd\/izad268","article-title":"Differential impact of smoking on methylome and transcriptome in Crohn\u2019s disease and ulcerative scolitis.","volume":"30","author":"Yan Ang","year":"2024","journal-title":"Inflamm Bowel Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12876-023-03043-4","article-title":"Platelet\/Albumin ratio and plateletcrit levels are potential new biomarkers for assessing endoscopic inflammatory bowel disease severity.","volume":"23","author":"Huang","year":"2023","journal-title":"BMC Gastroenterol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.13005\/bpj\/3058","article-title":"CRP\/albumin ratio as potential indicator for assessment of disease activity in inflammatory bowel disease patients.","volume":"17","author":"Mohamed","year":"2024","journal-title":"Biomed Pharmacol J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1080\/00365521.2021.1897670","article-title":"Increased use of biologics in the era of TNF-\u03b1 inhibitors did not reduce surgical rate but prolonged the time from diagnosis to first time intestinal resection among patients with Crohn\u2019s disease and ulcerative colitis\u2013a Danish register-based study from 2003\u20132016.","volume":"56","author":"Qvist","year":"2021","journal-title":"Scand J Gastroenterol."},{"key":"B30","first-page":"61","article-title":"Toxic ulcerative colitis and megacolon.","volume-title":"In Clinical Challenges and Complications of IBD.","author":"Cullen","year":"2024"},{"key":"B31","doi-asserted-by":"publisher","first-page":"150","DOI":"10.23922\/jarc.2023-060","article-title":"Surgical management for patients with toxic megacolon due to ulcerative colitis.","volume":"8","author":"Watanabe","year":"2024","journal-title":"J Anus Rectum Colon."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.3390\/nu16142302","article-title":"The effect of protein nutritional support on inflammatory bowel disease and its potential mechanisms.","volume":"16","author":"Li","year":"2024","journal-title":"Nutrients."},{"key":"B33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/1751-2980.13256","article-title":"Potential effects of nutrition-induced alteration of gut microbiota on inflammatory bowel disease: a review.","volume":"25","author":"Tian","year":"2024","journal-title":"J Dig Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.1007\/s10620-024-08543-1","article-title":"Elemental diet as a therapeutic modality: a comprehensive review.","volume":"69","author":"Nasser","year":"2024","journal-title":"Dig Dis Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21926\/rpn.2502010","article-title":"Exclusive enteral nutrition as an effective treatment in inflammatory bowel disease.","volume":"5","author":"P\u00e9rez-Gonz\u00e1lez","year":"2025","journal-title":"Recent Prog Nutr."},{"key":"B36","doi-asserted-by":"publisher","first-page":"17562848251323553","DOI":"10.1177\/17562848251323553","article-title":"Patient experiences with and adherence to Crohn\u2019s disease exclusion diet in Dutch Crohn\u2019s disease patients: a cohort study.","volume":"18","author":"Wijers","year":"2025","journal-title":"Ther Adv Gastroenterol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1053\/j.gastro.2023.11.303","article-title":"AGA clinical practice update on diet and nutritional therapies in patients with inflammatory bowel disease: expert Review.","volume":"166","author":"Hashash","year":"2024","journal-title":"Gastroenterology."},{"key":"B38","doi-asserted-by":"publisher","first-page":"103783","DOI":"10.1016\/j.ijnurstu.2020.103783","article-title":"Intermittent versus continuous enteral nutrition on feeding intolerance in critically ill adults: a meta-analysis of randomized controlled trials.","volume":"113","author":"Ma","year":"2021","journal-title":"Int J Nurs Stud."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1093\/ibd\/izac215","article-title":"Induction of remission with exclusive enteral nutrition in children with Crohn\u2019s disease: determinants of higher adherence and response.","volume":"29","author":"Cuomo","year":"2023","journal-title":"Inflamm Bowel Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.3390\/nu15061492","article-title":"Clinical impact of enteral protein nutritional therapy on patients with obesity scheduled for bariatric surgery: a focus on safety, efficacy, and pathophysiological changes.","volume":"15","author":"Castaldo","year":"2023","journal-title":"Nutrients."},{"key":"B41","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/00325481.2024.2307869","article-title":"Management of disease-related malnutrition: a real-world experience with a novel concentrated high-protein energy-dense oral nutritional supplement.","volume":"136","author":"L\u00f3pez-G\u00f3mez","year":"2024","journal-title":"Postgrad Med."},{"key":"B42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-81-322-2680-2_4","article-title":"Inflammation and inflammatory diseases, markers, and mediators: role of CRP in some inflammatory diseases.","volume-title":"In Biology of C Reactive Protein in Health and Disease.","author":"Ansar","year":"2016"},{"key":"B43","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/S2468-1253(21)00142-4","article-title":"Efficacy and safety of adalimumab in paediatric patients with moderate-to-severe ulcerative colitis (ENVISION I): a randomised, controlled, phase 3 study.","volume":"6","author":"Croft","year":"2021","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/S2468-1253(18)30231-0","article-title":"Comparative efficacy and tolerability of pharmacological agents for management of mild to moderate ulcerative colitis: a systematic review and network meta-analyses.","volume":"3","author":"Nguyen","year":"2018","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"101301","DOI":"10.1016\/j.eclinm.2022.101301","article-title":"Admission serum albumin concentrations and response to nutritional therapy in hospitalised patients at malnutrition risk: secondary analysis of a randomised clinical trial.","volume":"45","author":"Bretscher","year":"2022","journal-title":"EClinicalMedicine."},{"key":"B46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/gastroent14010006","article-title":"Systematic review of endoscopic management of stricture, fistula and abscess in inflammatory bowel disease.","volume":"14","author":"Pal","year":"2023","journal-title":"Gastroenterol Insights."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1759869\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:41:16Z","timestamp":1777437676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1759869\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":46,"alternative-id":["10.3389\/fnut.2026.1759869"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1759869","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"article-number":"1759869"}}